Abeona Therapeutics Inc.ABEONASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-84.30M
↓ 70% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-49.51M
Historical baseline
PeriodValueYoY Change
2025$-84.30M-44.2%
2024$-58.46M-56.6%
2023$-37.34M+14.4%
2022$-43.61M+37.5%
2021$-69.82M-92.0%
2020$-36.35M+47.6%
2019$-69.33M-18.3%
2018$-58.60M-146.3%
2017$-23.80M-75.8%
2016$-13.53M-